Salvage Surgery Due To Bowel Obstruction in Advanced or Relapsed Ovarian Cancer Resulting in Short Bowel Syndrome and Long-Life Total Parenteral Nutrition Surgical and Clinical Outcome

被引:18
作者
Fotopoulou, Christina [1 ,2 ]
Braicu, Elena Ioana [1 ]
Kwee, Sara-Lea [1 ]
Kuhberg, Marc [1 ]
Richter, Rolf [1 ]
Pietzner, Klaus [1 ]
Feldheiser, Aarne [3 ,4 ]
Bahra, Marcus [5 ]
Schmidt, Sven Christian [5 ]
Sehouli, Jalid [1 ]
机构
[1] Univ Hosp Rudolf Virchow, Dept Gynecol, European Competence Ctr Ovarian Canc, Charite,Campus Virchow Clin, D-13353 Berlin, Germany
[2] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Ovarian Canc Act Res Ctr, London, England
[3] Univ Med Berlin, Charite, Dept Anaesthesiol & Intens Care Med, Campus Virchow Klinikum, Berlin, Germany
[4] Campus Charite Mitte, Berlin, Germany
[5] Univ Hosp Rudolf Virchow, Dept Gen Visceral & Transplantat Surg, Charite, Campus Virchow Clin, D-13353 Berlin, Germany
关键词
Ovarian cancer; Tumor debulking; Bowel obstruction; Morbidity; Survival; Short bowel syndrome; PRIMARY PERITONEAL CANCER; EPITHELIAL OVARIAN; EXPLORATORY ANALYSIS; CONSECUTIVE PATIENTS; FALLOPIAN-TUBE; CYTOREDUCTION; MANAGEMENT; DISEASE; TRIAL;
D O I
10.1097/IGC.0b013e31829f81ca
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Salvage surgery for patients with highly advanced or relapsed epithelial ovarian cancer (EOC) complicated by bowel obstruction and resulting in short bowel syndrome (SBS) constitutes a therapeutic dilemma. Our aim was to evaluate surgical and clinical outcome in these highly palliative situations. Methods: We evaluated all patients with EOC who underwent salvage extraperitoneal en bloc intestinal resection with terminal ileostomy or jejunostomy resulting in SBS and total parenteral nutrition owing to bowel obstruction between May 2003 and January 2012 in our institution. Results: Thirty-seven patients were identified (median age, 58 years; range, 22-71 years), 3 (8.1%) with primary and 34 (91.6%) with relapsed EOC. Five patients (13.5%) were platinum sensitive. Median residual intestinal length was 70 cm (range, 10-180 cm); 21 patients (56.8%) had a residual intestinal length less than 1 m. Operative 30-day mortality and major morbidity rates were 10% and 51%, respectively. Median overall survival was 5.6 months (range, 0.1-49 months). One-year and 2-year overall survival rates were 18.3% (95% confidence interval, 5.1%-31.5%) and 8.1% (95% confidence interval, 0%-18.0)%, respectively. Within a median follow-up period of 5 months (range, 0.2-49 months), 4 patients (10.8%) are still alive. No significant differences in survival were seen between patients with or without major complications, tumor residuals, or residual intestinal length of less than 1 m versus greater than 1 m. Conclusions: Salvage palliative surgery in EOC due to bowel obstruction resulting in SBS and in need of long-life total parenteral nutrition is associated with high morbidity rates and low overall survival. These surgeries should ideally be performed only in a multidisciplinary setting with adequate infrastructure and possibility of home care support. Conservative management should be the route of action in the absence of acute abdomen or intestinal perforation.
引用
收藏
页码:1495 / 1500
页数:6
相关论文
共 18 条
[1]   Surgical standards in the management of ovarian cancer [J].
Bristow, RE .
CURRENT OPINION IN ONCOLOGY, 2000, 12 (05) :474-480
[2]   Overview of anti-angiogenic agents in development for ovarian cancer [J].
Burger, Robert A. .
GYNECOLOGIC ONCOLOGY, 2011, 121 (01) :230-238
[3]   Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: Redefining 'optimal' residual disease [J].
Chang, Suk-Joon ;
Bristow, Robert E. .
GYNECOLOGIC ONCOLOGY, 2012, 125 (02) :483-492
[4]   Is the Easier Way Ever the Better Way? [J].
Chi, Dennis S. ;
Bristow, Robert E. ;
Armstrong, Deborah K. ;
Karlan, Beth Y. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (31) :4073-4075
[5]   The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas [J].
Chi, Dennis S. ;
Zivanovic, Oliver ;
Levinson, Kimberly L. ;
Kolev, Valentin ;
Huh, Jae ;
Dottino, Joseph ;
Gardner, Ginger J. ;
Leitao, Mario M., Jr. ;
Levine, Douglas A. ;
Sonoda, Yukio ;
Abu-Rustum, Nadeem R. ;
Brown, Carol L. ;
Barakat, Richard R. .
GYNECOLOGIC ONCOLOGY, 2010, 119 (01) :38-42
[6]   Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach [J].
Chi, DS ;
Franklin, CC ;
Levine, DA ;
Akselrod, F ;
Sabbatini, P ;
Jarnagin, WR ;
DeMatteo, R ;
Poynor, EA ;
Abu-Rustum, NR ;
Barakat, RR .
GYNECOLOGIC ONCOLOGY, 2004, 94 (03) :650-654
[7]   2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004) [J].
du Bois, A ;
Quinn, M ;
Thigpen, T ;
Vermorken, J ;
Avall-Lundqvist, E ;
Bookman, M ;
Bowtell, D ;
Brady, M ;
Casado, A ;
Cervantes, A ;
Eisenhauer, E ;
Friedlaender, M ;
Fujiwara, K ;
Grenman, S ;
Guastalla, JP ;
Harper, P ;
Hogberg, T ;
Kaye, S ;
Kitchener, H ;
Kristensen, G ;
Mannel, R ;
Meier, W ;
Miller, B ;
Neijt, JP ;
Oza, A ;
Ozols, R ;
Parmar, M ;
Pecorelli, S ;
Pfisterer, J ;
Poveda, A ;
Provencher, D ;
Pujade-Lauraine, E ;
Randall, M ;
Rochon, J ;
Rustin, G ;
Sagae, S ;
Stehman, F ;
Stuart, G ;
Trimble, E ;
Vasey, P ;
Vergote, I ;
Verheijen, R ;
Wagner, U .
ANNALS OF ONCOLOGY, 2005, 16 :7-12
[8]   Role of Surgical Outcome as Prognostic Factor in Advanced Epithelial Ovarian Cancer: A Combined Exploratory Analysis of 3 Prospectively Randomized Phase 3 Multicenter Trials By the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO) [J].
du Bois, Andreas ;
Reuss, Alexander ;
Pujade-Lauraine, Eric ;
Harter, Philipp ;
Ray-Coquard, Isabelle ;
Pfisterer, Jacobus .
CANCER, 2009, 115 (06) :1234-1244
[9]   Can complete tumor resection be predicted in advanced primary epithelial ovarian cancer? A systematic evaluation of 360 consecutive patients [J].
Fotopoulou, C. ;
Richter, R. ;
Braicu, E. I. ;
Schmidt, S. -C. ;
Lichtenegger, W. ;
Sehouli, J. .
EJSO, 2010, 36 (12) :1202-1210
[10]   Clinical Outcome of Tertiary Surgical Cytoreduction in Patients with Recurrent Epithelial Ovarian Cancer [J].
Fotopoulou, Christina ;
Richter, Rolf ;
Braicu, Ioana Elena ;
Schmidt, Sven-Christian ;
Neuhaus, Peter ;
Lichtenegger, Werner ;
Sehouli, Jalid .
ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (01) :49-57